Either greater than 50 percent reduction in the total tumor load of all measurable masses determined by two studies at least four weeks apart (WHO criteria) or at least a 30 percent decrease in the sum of the longest diameter of up to 5 index tumors using the sum of the baseline longest diameters as a denominator (RECIST criteria)